The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest – Details, episodes & analysis
Podcast details
Technical and general information from the podcast's RSS feed.
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
Frequency: 1 episode/13d. Total Eps: 35
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Apple Podcasts
🇨🇦 Canada - lifeSciences
26/06/2026#95🇺🇸 USA - lifeSciences
17/06/2026#96🇺🇸 USA - lifeSciences
31/05/2026#96🇺🇸 USA - lifeSciences
07/05/2026#73🇨🇦 Canada - lifeSciences
03/05/2026#93🇺🇸 USA - lifeSciences
03/05/2026#75🇨🇦 Canada - lifeSciences
02/05/2026#78🇺🇸 USA - lifeSciences
02/05/2026#51🇨🇦 Canada - lifeSciences
01/05/2026#65🇺🇸 USA - lifeSciences
01/05/2026#74
Spotify
No recent rankings available
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
See allRSS feed quality and score
Technical evaluation of the podcast's RSS feed quality and structure.
See allScore global : 42%
Publication history
Monthly episode publishing history over the past years.
1: Introducing the Tell-Tale Heart Podcast
Episode 1
mardi 25 mars 2025 • Duration 04:21
3: Updates to Acute Coronary Syndrome Guidelines
Episode 3
mardi 8 avril 2025 • Duration 36:52
2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session
Episode 2
mardi 1 avril 2025 • Duration 01:20:05
This episode discussed multiple studies. See the list below for links to articles and relevant content:
REVERSE-IT trial data:
- https://www.pharmacytimes.com/view/acc-2025-ticagrelor-antidote-restores-platelet-function-treats-bleeding
- https://evidence.nejm.org/doi/full/10.1056/EVIDoa210004
- https://www.pharmacytimes.com/view/acc-2025-intravenous-iron-safe-but-results-in-mixed-findings-for-patients-with-heart-failure
- https://jamanetwork.com/journals/jama/fullarticle/2832132
- https://www.pharmacytimes.com/view/acc-2025-semaglutide-significantly-improves-walking-distance-symptoms-qol-for-individuals-with-pad-and-diabetes
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00509-4/abstract
FRESH-UP trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/17/26/fresh-up
FINEARTS-HF trial: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/03/05/17/27/FINEARTS-HF-Analysis
4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus
Episode 4
mardi 22 avril 2025 • Duration 39:02
For more information:
5: Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
Episode 5
mardi 6 mai 2025 • Duration 39:10
Show Notes:
- SELECT trial of semaglutide: https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
34: Putting the 2026 CKM Guidelines Into Practice: A Pharmacist's Perspective
Episode 34
mercredi 24 juin 2026 • Duration 33:41
33: Craig Beavers, PharmD Breaks Down the 2026 CKM Guidelines — And Why They Matter
Episode 33
mercredi 10 juin 2026 • Duration 12:09
25: How the POLY-HF Trial Shows Pharmacists' Key Role in Heart Failure Care
Episode 25
mardi 3 février 2026 • Duration 33:14
Learn more about the POLY-HF trial here.
You can reach the guests on this episode here:
Nick Miller, PharmD, on LinkedIn
- Nick Miller can be reached at nick@rxcompound.com
24: Hypertrophic Cardiomyopathy: What Pharmacists Need to Know in 2026
Episode 24
mardi 20 janvier 2026 • Duration 51:11
Join us for a deep dive into hypertrophic cardiomyopathy (HCM) with Andrew Williford, PharmD, an assistant professor and cardiology specialist at UC San Diego Health. In this episode, we break down the genetics, diagnosis, and clinical impact of HCM, explore how management strategies have evolved, and discuss the emerging role of cardiac myosin inhibitors in treating obstructive disease. Dr. Williford also shares insights from his telehealth GDMT titration clinic and offers practical guidance for pharmacists encountering HCM across care settings.
Show notes:
- Hypertrophic Cardiomyopathy Guideline Hub
- Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
- Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
- Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
23: Happy New Year from The Tell-Tale Heart!
Episode 23
mardi 6 janvier 2026 • Duration 01:44
Happy New Year from The Tell-Tale Heart! We'll be back in 2 weeks with a new episode. In the meantime, check out the recent episode of Drugstore Dialogue with host Barry Newman, who spoke with Craig Beavers about cardiology pharmacy.
Listen here: https://www.spreaker.com/episode/dr-craig-beavers--67706988
Related Shows Based on Content Similarities
